Tiffini Smith Voss MD
Movement Disorder, Neurodegenerative
VP, Clinical Development at PassageBio
Join to View Full Profile
Lee StGround floorCharlottesville, VA 22908
Phone+1 434-924-5542
Fax+1 434-982-1064
Dr. Voss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 2004 - 2007- University of Pennsylvania Health SystemInternship, Internal Medicine, 2003 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2003
Certifications & Licensure
VA State Medical License 2009 - 2026
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Efficacy of Rasagiline in Restless Legs Syndrome Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 4 citationsEffects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial.Yuki Mukai, Robert Lupinacci, Stephen Marder, Linda Snow-Adami, Tiffini Voss
Schizophrenia Research. 2024-08-01 - 2 citationsProgression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.Tiffini Voss, James Kost, Swati Pal Mercer, Christine Furtek, Christopher Randolph
Journal of Alzheimer's Disease. 2023-01-01 - An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's Disease.Susan J Lee, Peter M Shaw, Bob Thornton, Amit Kumar, Michal Eizik
Journal of Parkinson's Disease. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
